Pharmena SA
WSE:PHR
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
2.55
4.75
|
| Price Target |
|
We'll email you a reminder when the closing price reaches PLN.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Operating Margin
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Peer Comparison
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| PL |
P
|
Pharmena SA
WSE:PHR
|
45.3m PLN |
Loading...
|
|
| FR |
|
L'Oreal SA
PAR:OR
|
204.9B EUR |
Loading...
|
|
| UK |
|
Unilever PLC
LSE:ULVR
|
118.9B GBP |
Loading...
|
|
| IN |
|
Hindustan Unilever Ltd
NSE:HINDUNILVR
|
5.7T INR |
Loading...
|
|
| UK |
|
HALEON PLC
LSE:HLN
|
34.2B GBP |
Loading...
|
|
| US |
|
Estee Lauder Companies Inc
NYSE:EL
|
42.4B USD |
Loading...
|
|
| DE |
|
Beiersdorf AG
XETRA:BEI
|
21.4B EUR |
Loading...
|
|
| JP |
|
Kao Corp
TSE:4452
|
2.8T JPY |
Loading...
|
|
| IN |
|
Godrej Consumer Products Ltd
NSE:GODREJCP
|
1.3T INR |
Loading...
|
|
| IN |
|
Dabur India Ltd
NSE:DABUR
|
920.5B INR |
Loading...
|
|
| CA |
|
Relevium Technologies Inc
XTSX:RLV
|
12.2B CAD |
Loading...
|
Market Distribution
| Min | -10 083 900% |
| 30th Percentile | -1.5% |
| Median | 5.4% |
| 70th Percentile | 11.7% |
| Max | 195 905.3% |
Other Profitability Ratios
Pharmena SA
Glance View
PHARMENA SA engages in developing and marketing products based on a patented, physiological, and natural active substance 1-MNA. The company is headquartered in Lodz, Woj. Lodzkie and currently employs 24 full-time employees. The company went IPO on 2008-08-25. The Company’s products range encompasses Dermena, a line of products against hair loss; Dermena Plus, a shampoo reducing the symptoms of dandruff and preventing excessive hair loss; Accos, an anti-acne gel; Allerco, a line of hypo-allergic emollients for body care, Thermi, a gel after thermal burn and sunburn; and Revium, a line of anti-wrinkle treatment products. Pharmena SA maintains multidirectional research works and application studies in conjunction with a number of research centers in Europe, the United States and Canada. As of December 31, 2011, the Company had one wholly owned subsidiary, Cortria Corporation, based in the United States. As of December 31, 2011, Polska Grupa Farmaceutyczna SA held a 43.65% stake in the capital. The main shareholder of the Company is Pelion SA.
See Also
Operating Margin is calculated by dividing the Operating Income by the Revenue.
The current Operating Margin for Pharmena SA is -240%, which is below its 3-year median of 1 428.4%.
Over the last 3 years, Pharmena SA’s Operating Margin has decreased from -8.5% to -240%. During this period, it reached a low of -1 326.1% on Dec 31, 2022 and a high of 11 469.4% on Jun 30, 2024.